Home Amines 55837-30-4
55837-30-4,MFCD07364029
Catalog No.:AA0039IX

55837-30-4 | L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1)

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
95%
in stock  
$141.00   $99.00
- +
25g
95%
in stock  
$366.00   $257.00
- +
100g
95%
in stock  
$747.00   $523.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0039IX
Chemical Name:
L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1)
CAS Number:
55837-30-4
Molecular Formula:
C19H25ClN4O4
Molecular Weight:
408.8792
MDL Number:
MFCD07364029
SMILES:
OC(=O)c1cccnc1Nc1cccc(c1C)Cl.NCCCC[C@@H](C(=O)O)N
Properties
Computed Properties
 
Complexity:
407  
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
28  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
5  
Rotatable Bond Count:
8  

Downstream Synthesis Route
Literature

Title: Bioequivalence of 250 mg lysine clonixinate tablets after a single oral dose in a healthy female Mexican population under fasting conditions.

Journal: International journal of clinical pharmacology and therapeutics 20100501

Title: Analgesic efficacy of lysine clonixinate, paracetamol and dipyrone in lower third molar extraction: a randomized controlled trial.

Journal: Medicina oral, patologia oral y cirugia bucal 20090801

Title: Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: a single-blind, randomized study.

Journal: Arquivos de neuro-psiquiatria 20080601

Title: Lysine clonixinate vs naproxen sodium for the acute treatment of migraine: a double-blind, randomized, crossover study.

Journal: MedGenMed : Medscape general medicine 20050101

Title: Extraction and LC determination of lysine clonixinate salt in water/oil microemulsions.

Journal: Journal of pharmaceutical and biomedical analysis 20020201

Title: Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon.

Journal: Arzneimittel-Forschung 20011101

Title: In vivo and in vitro effects of lysine clonixinate on nitric oxide synthase in LPS-treated and untreated rat lung preparations.

Journal: Nitric oxide : biology and chemistry 20010401

Title: Oral lysine clonixinate in the acute treatment of migraine: a double-blind placebo-controlled study.

Journal: Arquivos de neuro-psiquiatria 20010301

Title: [Effects of lysine clonixinate on platelet function. Comparison with other non-steroidal anti-inflammatory agents].

Journal: Medicina 20010101

Title: Antispasmodic/analgesic associations in primary dysmenorrhea double-blind crossover placebo-controlled clinical trial.

Journal: International journal of clinical pharmacology research 20010101

Title: [Effect of nonsteroidal antiinflammatory drugs on colonic lipoxygenase and cyclooxygenase activities from patients with colonic neoplasia].

Journal: Medicina 20010101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 55837-30-4
Tags:55837-30-4 Molecular Formula|55837-30-4 MDL|55837-30-4 SMILES|55837-30-4 L-Lysine, 2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylate (1:1)